Received Jan 7, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | — | — |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 2 | — | — |
No additional AE; Pharmacist reported that she administered a dose of GARDASIL 9 to a patient today, 01/05/2026, who received their first dose on 09/22/2020.; This Spontaneous report was received from pharmacist and referred to a 19 -year-old female patient. The patient's medical history was not reported. The patient's past medications were not reported. The patient's concomitant medications were not reported. On 22-Sep-2020 (13-year-old), the patient was vaccinated with the first dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) injection (1.00 dosage form) Unknown Batch/Lot Number 1 dosage form, total. On 05-Jan-2026, the patient was vaccinated with the second dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) injection Unknown Batch/Lot Number, 1 dosage form, total. The patient started therapy with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) as prophylaxis (Inappropriate schedule of product administration). No symptoms reported. No additional AE (No adverse event).